Ticker Details
Oric Pharmaceuticals, Inc.
IPO Date:	April 24, 2020
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$1.16B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.46 | 3.62%
Avg Daily Range (30 D):	$0.44 | 4.17%
Avg Daily Range (90 D):	$0.40 | 3.80%

Institutional Daily Volume
Avg Daily Volume:	.47M
Avg Daily Volume (30 D):	1.89M
Avg Daily Volume (90 D):	1.54M

Trade Size
Avg Trade Size (Sh.):	84
Avg Trade Size (Sh.) (30 D):	95
Avg Trade Size (Sh.) (90 D):	88

Institutional Trades
Total Institutional Trades:	1,120
Avg Institutional Trade:	$1.67M
Avg Institutional Trade (30 D):	$2.19M
Avg Institutional Trade (90 D):	$2.11M
Avg Institutional Trade Volume:	.15M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$1.87M
Avg Closing Trade (30 D):	$2.99M
Avg Closing Trade (90 D):	$2.6M
Avg Closing Volume:	162.18K

News

Apr 3, 2026 @ 8:30 PM ORIC Pharmaceuticals Reports Inducement Grants und... Source: Oric Pharmaceuticals, Inc.

Apr 1, 2026 @ 6:48 AM ORIC Pharmaceuticals Stock Nosedives 25% After Hou... Source: Tanya Rawat

Jan 14, 2026 @ 3:52 PM Precision Killers: Why Big Pharma is Betting Billi... Source: Prnewswire

Dec 6, 2025 @ 1:00 AM ORIC® Pharmaceuticals Presents Potential Best-i... Source: Oric Pharmaceuticals

Dec 5, 2025 @ 2:45 AM ORIC® Pharmaceuticals Presents Potential Best-i... Source: Oric Pharmaceuticals

Financials
	TTM	Q4 2025	FY 2025
Basic EPS	$-1.47	$-.27	$-1.47
Diluted EPS	$-1.47	$-.27	$-1.47
Revenue	$M	$M	$M
Gross Profit
Net Income / Loss	$-129.47M	$-30.51M	$-129.47M
Operating Income / Loss	$-143M	$-34.55M	$-143M
Cost of Revenue
Net Cash Flow	$-13.74M	$-4M	$-13.74M
PE Ratio